Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2020 Filed Dec 15, 2020 22:27 UTC |
Albright John PDirector · PRESIDENT & CEO
|
SaleCommon Stock | 1,300 | $41.04 | $53,345.63 |
DisclosureSEC source: 0001415889-20-002900 · form4-12152020_021205.xml · nonDerivative · entry 1 Albright John P · CIK 0001392476 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,306 F1 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: This amount includes 13,558 shares of restricted common stock which vest over time, and 22,000 shares of restricted common stock which vest based on share price appreciation, both of which were previously reported. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:46 UTC |
WOLD CASEY RDirector
|
GrantCommon Stock | 302 | $44.10 | $13,318.20 |
DisclosureSEC source: 0001415889-20-002415 · form4-10022020_031022.xml · nonDerivative · entry 1 WOLD CASEY R · CIK 0001169255 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,808 F1 · price: These shares were issued to the Reporting Person in lieu of his 3rd quarter 2020 retainer fee of $10,000 and meeting fees of $3,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $43.0310. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:44 UTC |
FRANKLIN LAURA MDirector
|
GrantCommon Stock | 302 | $44.10 | $13,318.20 |
DisclosureSEC source: 0001415889-20-002413 · form4-10022020_031045.xml · nonDerivative · entry 1 FRANKLIN LAURA M · CIK 0001165972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,932 F1 · price: These shares were issued to the Reporting Person in lieu of her 3rd quarter 2020 retainer fee of $10,000 and meeting fees of $3,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $43.0310. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:43 UTC |
Serkin Howard CDirector
|
GrantCommon Stock | 371 | $44.10 | $16,361.10 |
DisclosureSEC source: 0001415889-20-002411 · form4-10022020_031000.xml · nonDerivative · entry 1 Serkin Howard C · CIK 0001511874 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,674 F1 · price: These shares were issued to the Reporting Person in lieu of his 3rd quarter 2020 retainer fee of $10,000 and meeting fees of $6,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $43.0310. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:30 UTC |
Gable Robert BlakesleeDirector
|
GrantCommon Stock | 348 | $44.10 | $15,346.80 |
DisclosureSEC source: 0001415889-20-002408 · form4-10022020_061021.xml · nonDerivative · entry 1 Gable Robert Blakeslee · CIK 0001757398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,760 F1 · price: These shares were issued to the Reporting Person in lieu of his 3rd quarter 2020 retainer fee of $10,000 and meeting fees of $5,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $43.0310. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:30 UTC |
Brokaw George RDirector
|
GrantCommon Stock | 302 | $44.10 | $13,318.20 |
DisclosureSEC source: 0001415889-20-002405 · form4-10022020_061006.xml · nonDerivative · entry 1 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,463 F1 · price: These shares were issued to the Reporting Person in lieu of his 3rd quarter 2020 retainer fee of $10,000 and meeting fees of $3,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $43.0310. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:30 UTC |
Haga Christopher WDirector
|
GrantCommon Stock | 360 | $44.10 | $15,876.00 |
DisclosureSEC source: 0001415889-20-002404 · form4-10022020_061001.xml · nonDerivative · entry 1 Haga Christopher W · CIK 0001619039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,163 F1 · price: These shares were issued to the Reporting Person in lieu of his 3rd quarter 2020 retainer fee of $10,000 and meeting fees of $5,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $43.0310. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:05 UTC |
PARTRIDGE MATTHEW MORRISSR. VP & CFO
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-002433 · form4-10052020_071001.xml · nonDerivative · entry 1 PARTRIDGE MATTHEW MORRIS · CIK 0001663789 · SR. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Restricted shares one-half of which vest on each of January 28, 2022, and January 28, 2023, provided that the reporting person is an employee of the Issuer on those dates. F2 · balance_after: This amount includes 4,000 restricted shares, which vest over time. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:05 UTC |
Haga Christopher WDirector
|
PurchaseCommon Stock | 1,200 | $43.74 | $52,489.44 |
DisclosureSEC source: 0001415889-20-002314 · form4-09162020_040901.xml · nonDerivative · entry 1 Haga Christopher W · CIK 0001619039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By the reporting person as UGMA custodian Disclosed balance after: 1,200 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.71 to $43.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| August 05, 2020 Filed Aug 5, 2020 20:52 UTC |
Brokaw George RDirector
|
PurchaseCommon Stock | 414 | $40.97 | $16,960.63 |
DisclosureSEC source: 0001415889-20-002041 · form4-08052020_010835.xml · nonDerivative · entry 4 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,161 Read SEC document |
| August 05, 2020 Filed Aug 5, 2020 20:52 UTC |
Brokaw George RDirector
|
PurchaseCommon Stock | 56 | $40.50 | $2,268.00 |
DisclosureSEC source: 0001415889-20-002041 · form4-08052020_010835.xml · nonDerivative · entry 3 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,747 Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:52 UTC |
Brokaw George RDirector
|
PurchaseCommon Stock | 500 | $40.25 | $20,124.00 |
DisclosureSEC source: 0001415889-20-002041 · form4-08052020_010835.xml · nonDerivative · entry 2 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,691 Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:52 UTC |
Brokaw George RDirector
|
PurchaseCommon Stock | 1,000 | $40.35 | $40,352.00 |
DisclosureSEC source: 0001415889-20-002041 · form4-08052020_010835.xml · nonDerivative · entry 1 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,191 Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:09 UTC |
Brokaw George RDirector
|
GrantCommon Stock | 312 | $41.61 | $12,981.54 |
DisclosureSEC source: 0001415889-20-001805 · form4-07022020_040715.xml · nonDerivative · entry 1 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,191 F1 · price: These shares were issued to the Reporting Person in lieu of his 2nd quarter 2020 retainer fee of $10,000 and meeting fees of $3,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $41.6075. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:09 UTC |
Serkin Howard CDirector
|
GrantCommon Stock | 324 | $41.61 | $13,480.83 |
DisclosureSEC source: 0001415889-20-001804 · form4-07022020_040751.xml · nonDerivative · entry 1 Serkin Howard C · CIK 0001511874 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,303 F1 · price: These shares were issued to the Reporting Person in lieu of his 2nd quarter 2020 retainer fee of $10,000 and meeting fees of $3,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $41.6075. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:08 UTC |
FRANKLIN LAURA MDirector
|
GrantCommon Stock | 312 | $41.61 | $12,981.54 |
DisclosureSEC source: 0001415889-20-001803 · form4-07022020_040731.xml · nonDerivative · entry 1 FRANKLIN LAURA M · CIK 0001165972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,630 F1 · price: These shares were issued to the Reporting Person in lieu of her 2nd quarter 2020 retainer fee of $10,000 and meeting fees of $3,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $41.6075. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:08 UTC |
Haga Christopher WDirector
|
GrantCommon Stock | 312 | $41.61 | $12,981.54 |
DisclosureSEC source: 0001415889-20-001802 · form4-07022020_040719.xml · nonDerivative · entry 1 Haga Christopher W · CIK 0001619039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,803 F1 · price: These shares were issued to the Reporting Person in lieu of his 2nd quarter 2020 retainer fee of $10,000 and meeting fees of $3,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $41.6075. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:08 UTC |
Gable Robert BlakesleeDirector
|
GrantCommon Stock | 312 | $41.61 | $12,981.54 |
DisclosureSEC source: 0001415889-20-001801 · form4-07022020_040741.xml · nonDerivative · entry 1 Gable Robert Blakeslee · CIK 0001757398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,412 F1 · price: These shares were issued to the Reporting Person in lieu of his 2nd quarter 2020 retainer fee of $10,000 and meeting fees of $3,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $41.6075. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:07 UTC |
WOLD CASEY RDirector
|
GrantCommon Stock | 288 | $41.61 | $11,982.96 |
DisclosureSEC source: 0001415889-20-001799 · form4-07022020_040710.xml · nonDerivative · entry 1 WOLD CASEY R · CIK 0001169255 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,506 F1 · price: These shares were issued to the Reporting Person in lieu of his 2nd quarter 2020 retainer fee of $10,000 and meeting fees of $2,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $41.6075. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:15 UTC |
Albright John PDirector · PRESIDENT & CEO
|
GiftCommon Stock | 134 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001603 · form4-06122020_040601.xml · nonDerivative · entry 1 Albright John P · CIK 0001392476 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,606 F1 · kind: On 6/11/2020, the reporting person donated 134 shares to a non-profit organization. F2 · balance_after: This amount includes 13,558 shares of restricted common stock which vest over time, and 22,000 shares of restricted common stock which vest based on share price appreciation, both of which were previously reported. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:20 UTC |
Albright John PDirector · PRESIDENT & CEO
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001222 · form4-05152020_040501.xml · nonDerivative · entry 1 Albright John P · CIK 0001392476 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,740 F1 · kind: On 5/14/2020, the reporting person donated 100 shares to a non-profit organization. F2 · balance_after: This amount includes 13,558 shares of restricted common stock which vest over time, and 22,000 shares of restricted common stock which vest based on share price appreciation, both of which were previously reported. Read SEC document |
| May 14, 2020 Filed May 15, 2020 20:15 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
PurchaseCommon Stock | 500 | $36.76 | $18,379.00 |
DisclosureSEC source: 0001415889-20-001221 · form4-05152020_040506.xml · nonDerivative · entry 1 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,380 F1 · shares: The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $36.55 to $36.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · balance_after: This amount includes 3,910 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:15 UTC Amendment |
Brokaw George RDirector
|
PurchaseCommon Stock | 748 | $39.65 | $29,658.20 |
DisclosureSEC source: 0001415889-20-001164 · form4a-05122020_040501.xml · nonDerivative · entry 3 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879 Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:15 UTC Amendment |
Brokaw George RDirector
|
PurchaseCommon Stock | 52 | $39.55 | $2,056.60 |
DisclosureSEC source: 0001415889-20-001164 · form4a-05122020_040501.xml · nonDerivative · entry 2 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,131 Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:15 UTC Amendment |
Brokaw George RDirector
|
PurchaseCommon Stock | 200 | $39.60 | $7,920.00 |
DisclosureSEC source: 0001415889-20-001164 · form4a-05122020_040501.xml · nonDerivative · entry 1 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,079 Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:05 UTC |
WOLD CASEY RDirector
|
GrantCommon Stock | 441 | $46.39 | $20,456.67 |
DisclosureSEC source: 0001415889-20-000933 · form4-04022020_040429.xml · nonDerivative · entry 1 WOLD CASEY R · CIK 0001169255 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,218 F1 · price: These shares were issued to the Reporting Person in lieu of his 1st quarter 2020 retainer fee of $10,000 and meeting fees of $10,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $46.387. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:05 UTC |
Serkin Howard CDirector
|
GrantCommon Stock | 420 | $46.39 | $19,482.54 |
DisclosureSEC source: 0001415889-20-000932 · form4-04022020_040424.xml · nonDerivative · entry 1 Serkin Howard C · CIK 0001511874 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,979 F1 · price: These shares were issued to the Reporting Person in lieu of his 1st quarter 2020 retainer fee of $10,000 and meeting fees of $9,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $46.387. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:05 UTC |
Haga Christopher WDirector
|
GrantCommon Stock | 463 | $46.39 | $21,477.18 |
DisclosureSEC source: 0001415889-20-000931 · form4-04022020_040418.xml · nonDerivative · entry 1 Haga Christopher W · CIK 0001619039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,491 F1 · price: These shares were issued to the Reporting Person in lieu of his 1st quarter 2020 retainer fee of $10,000 and meeting fees of $11,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $46.387. F2 · balance_after: The Reporting Person serves as Head of Strategic Investments at Carlson Capital, L.P. ("Carlson Capital"). Carlson Capital may be deemed to beneficially own 162,617 shares of Common Stock of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer beneficially owned by Carlson Capital. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:05 UTC |
Gable Robert BlakesleeDirector
|
GrantCommon Stock | 377 | $46.39 | $17,487.90 |
DisclosureSEC source: 0001415889-20-000930 · form4-04022020_040411.xml · nonDerivative · entry 1 Gable Robert Blakeslee · CIK 0001757398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 F1 · price: These shares were issued to the Reporting Person in lieu of his 1st quarter 2020 retainer fee of $10,000 and meeting fees of $7,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $46.387. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:05 UTC |
FRANKLIN LAURA MDirector
|
GrantCommon Stock | 344 | $46.39 | $15,957.13 |
DisclosureSEC source: 0001415889-20-000929 · form4-04022020_040406.xml · nonDerivative · entry 1 FRANKLIN LAURA M · CIK 0001165972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,318 F1 · price: These shares were issued to the Reporting Person in lieu of her 1st quarter 2020 retainer fee of $10,000 and meeting fees of $6,000 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $46.387. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:05 UTC |
Brokaw George RDirector
|
GrantCommon Stock | 377 | $46.39 | $17,487.90 |
DisclosureSEC source: 0001415889-20-000928 · form4-04022020_040401.xml · nonDerivative · entry 1 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,803 F1 · price: These shares were issued to the Reporting Person in lieu of his 1st quarter 2020 retainer fee of $10,000 and meeting fees of $7,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last day of the quarter, or $46.3870. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 18:25 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
PurchaseCommon Stock | 250 | $48.50 | $12,125.00 |
DisclosureSEC source: 0001415889-20-000752 · form4-03162020_020316.xml · nonDerivative · entry 4 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,880 F1 · balance_after: This amount includes 3,910 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 18:25 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
PurchaseCommon Stock | 200 | $49.00 | $9,800.00 |
DisclosureSEC source: 0001415889-20-000752 · form4-03162020_020316.xml · nonDerivative · entry 3 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,630 F1 · balance_after: This amount includes 3,910 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 18:25 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
PurchaseCommon Stock | 100 | $49.62 | $4,961.78 |
DisclosureSEC source: 0001415889-20-000752 · form4-03162020_020316.xml · nonDerivative · entry 2 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,430 F1 · balance_after: This amount includes 3,910 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 18:25 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
PurchaseCommon Stock | 100 | $49.62 | $4,962.00 |
DisclosureSEC source: 0001415889-20-000752 · form4-03162020_020316.xml · nonDerivative · entry 1 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,330 F1 · balance_after: This amount includes 3,910 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 18:30 UTC |
Greathouse Steven RobertSVP-INVESTMENTS
|
PurchaseCommon Stock | 415 | $49.50 | $20,542.50 |
DisclosureSEC source: 0001415889-20-000753 · form4-03162020_020301.xml · nonDerivative · entry 1 Greathouse Steven Robert · CIK 0001728277 · SVP-INVESTMENTS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,727 F1 · balance_after: This amount includes 4,505 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:10 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
GrantCommon Stock | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000499 · form4-02262020_040215.xml · nonDerivative · entry 1 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,230 F1 · shares: Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2020, provided that the reporting person is an employee of the Issuer on those dates. The fair market value of the common stock on the date of the grant was $62.47 per share, but the fair market value of the award when vested will be the fair market value of the common stock on each vesting date. F2 · balance_after: This amount includes the 1,940 restricted shares reported above, as well as 1,970 additional shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:10 UTC |
Patten Mark ESVP & CFO
|
GrantCommon Stock | 2,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000498 · form4-02262020_040211.xml · nonDerivative · entry 1 Patten Mark E · CIK 0001282528 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,308 F1 · shares: Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2020, provided that the reporting person is an employee of the Issuer on those dates. The fair market value of the common stock on the date of the grant was $62.47 per share, but the fair market value of the award when vested will be the fair market value of the common stock on each vesting date. F2 · balance_after: This amount includes the 2,156 restricted shares reported above, as well as 2,157 additional shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:10 UTC |
Greathouse Steven RobertSVP-INVESTMENTS
|
GrantCommon Stock | 2,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000497 · form4-02262020_040206.xml · nonDerivative · entry 1 Greathouse Steven Robert · CIK 0001728277 · SVP-INVESTMENTS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,312 F1 · shares: Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2020, provided that the reporting person is an employee of the Issuer on those dates. The fair market value of the common stock on the date of the grant was $62.47 per share, but the fair market value of the award when vested will be the fair market value of the common stock on each vesting date. F2 · balance_after: This amount includes the 2,352 restricted shares reported above, as well as 2,153 additional shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:10 UTC |
Albright John PDirector · PRESIDENT & CEO
|
GrantCommon Stock | 6,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000496 · form4-02262020_040201.xml · nonDerivative · entry 1 Albright John P · CIK 0001392476 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,840 F1 · shares: Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2020, provided that the reporting person is an employee of the Issuer on those dates. The fair market value of the common stock on the date of the grant was $62.47 per share, but the fair market value of the award when vested will be the fair market value of the common stock on each vesting date. F2 · balance_after: This amount includes the 6,644 restricted shares reported above, as well as 6,914 additional shares of restricted common stock which vest over time, and 22,000 shares of restricted common stock which vest based on share price appreciation, both of which were previously reported. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:05 UTC |
WOLD CASEY RDirector
|
GrantCommon Stock | 313 | $63.78 | $19,962.20 |
DisclosureSEC source: 0001415889-20-000495 · form4-02262020_040227.xml · nonDerivative · entry 1 WOLD CASEY R · CIK 0001169255 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,777 F1 · price: These shares were issued to the Reporting Person as his $20,000 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy adopted by the Issuer's board of directors on February 27, 2019. The share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 10, 2020, or $63.777. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:05 UTC |
Serkin Howard CDirector
|
GrantCommon Stock | 313 | $63.78 | $19,962.20 |
DisclosureSEC source: 0001415889-20-000494 · form4-02262020_040221.xml · nonDerivative · entry 1 Serkin Howard C · CIK 0001511874 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,559 F1 · price: These shares were issued to the Reporting Person as his $20,000 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy adopted by the Issuer's board of directors on February 27, 2019. The share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 10, 2020, or $63.777. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:05 UTC |
Haga Christopher WDirector
|
GrantCommon Stock | 313 | $63.78 | $19,962.20 |
DisclosureSEC source: 0001415889-20-000493 · form4-02262020_040215.xml · nonDerivative · entry 1 Haga Christopher W · CIK 0001619039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,028 F1 · price: These shares were issued to the Reporting Person as his $20,000 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy adopted by the Issuer's board of directors on February 27, 2019. The share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 10, 2020, or $63.777. F2 · balance_after: The Reporting Person is a partner and serves as Head of Strategic Investments at Carlson Capital, L.P. ("Carlson Capital"). Carlson Capital may be deemed to beneficially own 162,617 shares of Common Stock of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer beneficially owned by Carlson Capital. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:05 UTC |
Gable Robert BlakesleeDirector
|
GrantCommon Stock | 313 | $63.78 | $19,962.20 |
DisclosureSEC source: 0001415889-20-000492 · form4-02262020_040210.xml · nonDerivative · entry 1 Gable Robert Blakeslee · CIK 0001757398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,723 F1 · price: These shares were issued to the Reporting Person as his $20,000 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy adopted by the Issuer's board of directors on February 27, 2019. The share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 10, 2020, or $63.777. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:05 UTC |
Brokaw George RDirector
|
GrantCommon Stock | 313 | $63.78 | $19,962.20 |
DisclosureSEC source: 0001415889-20-000490 · form4-02262020_040201.xml · nonDerivative · entry 1 Brokaw George R · CIK 0001589074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,426 F1 · price: These shares were issued to the Reporting Person as his $20,000 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019. Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 24, 2020, or $62.47. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:05 UTC |
FRANKLIN LAURA MDirector
|
GrantCommon Stock | 313 | $63.78 | $19,962.20 |
DisclosureSEC source: 0001415889-20-000491 · form4-02262020_040206.xml · nonDerivative · entry 1 FRANKLIN LAURA M · CIK 0001165972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,974 F1 · price: These shares were issued to the Reporting Person as her $20,000 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy adopted by the Issuer's board of directors on February 27, 2019. The share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 10, 2020, or $63.777. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:15 UTC |
Greathouse Steven RobertSVP-INVESTMENTS
|
Tax withholdingCommon Stock | 542 | $61.43 | $33,295.06 |
DisclosureSEC source: 0001415889-20-000319 · form4-02132020_040214.xml · nonDerivative · entry 2 Greathouse Steven Robert · CIK 0001728277 · SVP-INVESTMENTS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,960 F3 · shares: On February 11, 2020, the Reporting Person instructed the Issuer to withhold 542 of the Issued Shares to satisfy the Reporting Person's tax liability. F4 · balance_after: This amount includes 2,153 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:15 UTC |
Greathouse Steven RobertSVP-INVESTMENTS
|
GrantCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000319 · form4-02132020_040214.xml · nonDerivative · entry 1 Greathouse Steven Robert · CIK 0001728277 · SVP-INVESTMENTS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,502 F1 · shares: On February 11, 2020, the Issuer issued 2,250 shares of its common stock (the "Issued Shares") to the Reporting Person. The Issued Shares were issued pursuant to a Performance Shares Award Agreement between the Issuer and the Reporting Person dated February 3, 2017, the form of which has been filed as an exhibit to the Issuer's annual report on Form 10-K for the year ended December 31, 2018. F2 · balance_after: This amount includes 2,153 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:15 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
Tax withholdingCommon Stock | 541 | $61.43 | $33,233.63 |
DisclosureSEC source: 0001415889-20-000317 · form4-02132020_040205.xml · nonDerivative · entry 2 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,290 F3 · shares: On February 11, 2020, the Reporting Person instructed the Issuer to withhold 541 of the Issued Shares to satisfy the Reporting Person's tax liability. F4 · balance_after: This amount includes 1,970 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:15 UTC |
Smith Daniel EarlSVP, GEN COUNSEL & CORP SECRET
|
GrantCommon Stock | 2,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-000317 · form4-02132020_040205.xml · nonDerivative · entry 1 Smith Daniel Earl · CIK 0001623528 · SVP, GEN COUNSEL & CORP SECRET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,831 F1 · shares: On February 11, 2020, the Issuer issued 2,250 shares of its common stock (the "Issued Shares") to the Reporting Person. The Issued Shares were issued pursuant to a Performance Shares Award Agreement between the Issuer and the Reporting Person dated February 3, 2017, the form of which has been filed as an exhibit to the Issuer's annual report on Form 10-K for the year ended December 31, 2018. F2 · balance_after: This amount includes 1,970 shares of restricted common stock which vest over time, which were previously reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.